Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 3
1974 2
1977 1
1988 2
1989 1
1990 2
1991 1
1992 1
1993 3
1995 1
1998 2
2002 1
2003 1
2004 3
2005 2
2006 2
2007 4
2008 5
2009 3
2010 3
2011 5
2012 7
2013 7
2014 12
2015 18
2016 9
2017 9
2018 17
2019 8
2020 7
2021 5
2022 5
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy.
Farncombe KM, Wong D, Norman ML, Oldfield LE, Sobotka JA, Basik M, Bombard Y, Carile V, Dawson L, Foulkes WD, Malkin D, Karsan A, Parkin P, Penney LS, Pollett A, Schrader KA, Pugh TJ, Kim RH; CHARM consortium. Farncombe KM, et al. Am J Hum Genet. 2023 Oct 5;110(10):1616-1627. doi: 10.1016/j.ajhg.2023.08.014. Am J Hum Genet. 2023. PMID: 37802042 Free PMC article. Review.
Wilderness-Telemedicine, a New Training Paradigm.
Lafleur J, Sikka N, Hood C. Lafleur J, et al. Wilderness Environ Med. 2022 Dec;33(4):488-489. doi: 10.1016/j.wem.2022.06.001. Epub 2022 Sep 16. Wilderness Environ Med. 2022. PMID: 36123274 No abstract available.
Recent advances in lab-on-a-chip for biosensing applications.
Lafleur JP, Jönsson A, Senkbeil S, Kutter JP. Lafleur JP, et al. Biosens Bioelectron. 2016 Feb 15;76:213-33. doi: 10.1016/j.bios.2015.08.003. Epub 2015 Aug 13. Biosens Bioelectron. 2016. PMID: 26318580 Review.
COVID-19 Convalescent Plasma Therapy: Long-term Implications.
Yoon H, Li Y, Goldfeld KS, Cobb GF, Sturm-Reganato CL, Ostrosky-Zeichner L, Jayaweera DT, Philley JV, Desruisseaux MS, Keller MJ, Hochman JS, Pirofski LA, Ortigoza MB; CONTAIN-Extend Study Group. Yoon H, et al. Open Forum Infect Dis. 2023 Dec 29;11(1):ofad686. doi: 10.1093/ofid/ofad686. eCollection 2024 Jan. Open Forum Infect Dis. 2023. PMID: 38269049 Free PMC article.
Determining Multiple Sclerosis Phenotype from Electronic Medical Records.
Nelson RE, Butler J, LaFleur J, Knippenberg K, C Kamauu AW, DuVall SL. Nelson RE, et al. Among authors: lafleur j. J Manag Care Spec Pharm. 2016 Dec;22(12):1377-1382. doi: 10.18553/jmcp.2016.22.12.1377. J Manag Care Spec Pharm. 2016. PMID: 27882837 Free PMC article.
Fatigue: implications for the elderly.
Wick JY, LaFleur J. Wick JY, et al. Among authors: lafleur j. Consult Pharm. 2007 Jul;22(7):566-70, 573-4, 576-8. doi: 10.4140/tcp.n.2007.566. Consult Pharm. 2007. PMID: 17714001 Review.
146 results